Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer

Background. Circulating tumor DnA (ctDnA) may act as a potential biomarker for predicting disease progression in patients with colorectal cancer (CRC), which are radically cured or receiving chemotherapy.Objective: to evaluate the sensitivity of the investigated ctDnA detection assay and quantify th...

Full description

Bibliographic Details
Main Authors: E. M. Polyanskaya, M. Yu.  Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, A. N. Polyakov, N. E. Kudashkin, D. V. Podluzhniy, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mamedli, A. A. Tryakin, M. L. Filipenko, S. A. Tjulandin
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2022-04-01
Series:Тазовая хирургия и онкология
Subjects:
Online Access:https://ok.abvpress.ru/jour/article/view/526